Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Geriatric assessment-adapted therapy for Ph-negative acute lymphoblastic leukemia in elderly patients
2005-002156-17Phase 2Completed
- Sponsor
- GIMEMA
- Start
- May 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of prednisone, methylprednisolone, vinblastine, vincristine, daunorubicin and 5 more in acute lymphoblastic leukemia (ALL), sponsored by GIMEMA. Primary endpoint: overall survival. Started May 2007; status: completed.
02
Drugs
prednisonemethylprednisolonevinblastinevincristinedaunorubicin
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on 2005-002156-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002156-17.